@article{hershberger2023rare,
 abstract = {BACKGROUND: Dilated cardiomyopathy (DCM) can lead to advanced disease, defined herein as necessitating a durable left ventricular assist device or a heart transplant (LVAD/HT). DCM is known to have a genetic basis, but the association of rare variant genetics with advanced DCM has not been studied. METHODS: We analyzed clinical and genetic sequence data from patients enrolled between 2016 and 2021 in the US multisite DCM Precision Medicine Study, which was a geographically diverse, multiracial, multiethnic cohort. Clinical evaluation included standardized patient interview and medical record q...},
 author = {MD Ray E. Hershberger and MD Mauro Giacca and MD Mark Hofmeyer and MD Garrie J. Haas and MS Elizabeth Jordan and MS Jinwen Cao and MD Evan Kransdorf and PhD Gregory A. Ewald and MD Alanna A. Morris and MSc Anjali Owens Md and M. Lowes and P. Stoller and P. W. Tang and Mamta Garg and Marija Trachtenberg and M. Shah and M. Md and Michael Sweitzer and P. M. Wheeler and Priya Md and M. S. Katz and M. Pan and M. Md and Pippa Smart and MD Jessica Wang and M. Gottlieb and M. Judge and M. K. Moore and M. Huggins and M. D. D. Kinnamon and P. Ni},
 doi = {10.1161/CIRCULATIONAHA.123.064847},
 journal = {Circulation},
 pages = {872 - 881},
 title = {Rare variant genetics and dilated cardiomyopathy severity: The DCM Precision Medicine Study},
 volume = {148},
 year = {2023}
}